Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

BioCryst Pharmaceuticals Inc (NASDAQ:BCRX)

5.51
Delayed Data
As of 3:59pm ET
 +0.335 / +6.47%
Today’s Change
1.63
Today|||52-Week Range
10.98
-46.61%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues26.3M17.3M13.6M48.3M
 
 
 
 
 
Cost of Goods Sold132.0K98.0K33.5K1.7M
 
 
 
 
 
Depreciation And Amortization628.0K304.0K177.0K180.0K
 
 
 
 
 
 
Operating ExpensesGross Income25.5M16.9M13.4M46.4M
 
 
 
 
 
General Expenses56.2M42.6M59.2M85.8M
 
 
 
 
 
Research And Development51.5M37.7M51.8M72.8M
 
 
 
 
 
Total Operating Expenses56.9M43.0M59.4M87.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-30.6M-25.7M-45.8M-39.4M
 
 
 
 
 
Extraordinary Credit0.005.3M5.5M1.1M
 
 
 
 
Extraordinary Charge-4.0M-5.0M0.000.00
 
 
 
Interest Expense On Debt4.7M4.8M5.0M5.2M
 
 
 
 
 
Other Expenses0.000.000.0013.0K
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-39.1M-30.1M-45.2M-43.0M
 
 
 
 
 
Net Income-39.1M-30.1M-45.2M-43.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS49.5M55.2M66.8M72.9M
 
 
 
 
 
Shares To Calculate EPS Diluted49.5M55.2M66.8M72.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.79-$0.55-$0.68-$0.59
 
 
 
 
 
EPS Diluted-$0.79-$0.55-$0.68-$0.59